Key result
This review discusses the pathophysiology of thrombosis, challenges in identifying at-risk patients, management options, and the development of new anticoagulants to replace traditional agents.
This review highlights the challenges in identifying patients at risk for venous thromboembolism and discusses current management options, including the development of new anticoagulants.
Answers are grounded in this paper and cite their sources.
Challenges persist in VTE risk stratification; leaves open optimal use of emerging anticoagulants pending prospective data.
The devastating consequences of venous thromboembolism have forever provided the impetus to explore safe and effective treatment strategies. To date, the pathophysiology and mechanism of thrombosis have been extensively studied and details of new thrombophilic conditions are continually being discovered. Although there has been extensive research detailing various predispositions to thrombosis, uncertainties regarding their appropriate management continue. This review aims to highlight the various challenges involved in identifying those at risk; provide appropriate management options; and lastly present the current views on the development of new anticoagulants that are competing to replace the traditional agents.
No takes yet. Share an insight, caveat, or question.
Sarvananthan et al. (2012) conducted a review in Venous thromboembolism. This review discusses the pathophysiology of thrombosis, challenges in identifying at-risk patients, management options, and the development of new anticoagulants to replace traditional agents.
Synapse has enriched 10 related papers. Consider them for comparative context: